Daniel C Malone
Overview
Explore the profile of Daniel C Malone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
221
Citations
2897
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lumbreras A, Hurwitz J, Liang X, Schippers S, Phillip K, Bhattacharjee S, et al.
J Manag Care Spec Pharm
. 2024 Mar;
30(4):313-325.
PMID: 38555623
Background: In the last decade there has been an increase in the development and marketing of digital therapeutic (DTx) products aiming to prevent, manage, or treat a medical disorder or...
12.
Dayer V, Drummond M, Dabbous O, Toumi M, Neumann P, Tunis S, et al.
Orphanet J Rare Dis
. 2024 Feb;
19(1):47.
PMID: 38326894
Health technology assessment (HTA) decisions for pharmaceuticals are complex and evolving. New rare disease treatments are often approved more quickly through accelerated approval schemes, creating more uncertainties about clinical evidence...
13.
Ghule P, Panic J, Malone D
Am J Health Syst Pharm
. 2024 Jan;
81(12):494-508.
PMID: 38263263
Purpose: Oral anticoagulants (OACs) and aspirin can trigger bleeding events when used alone or in combination. The purpose of this study was to compare the risk of any type of...
14.
Johnston K, Audhya I, Dunne J, Feeny D, Neumann P, Malone D, et al.
Appl Health Econ Health Policy
. 2024 Jan;
22(3):343-352.
PMID: 38253973
Objectives: There is increasing interest in expanding the elements of value to be considered when making health policy decisions. To help inform value frameworks, this study quantified preferences for disease...
15.
Audhya I, Szabo S, Bever A, OSullivan F, Malone D, Feeny D, et al.
J Patient Rep Outcomes
. 2023 Dec;
7(1):132.
PMID: 38100005
Background: The progression of Duchenne muscular dystrophy (DMD) is characterized by loss of ambulation, respiratory insufficiency, cardiomyopathy, and early mortality. DMD profoundly impacts health-related quality-of-life (HRQoL). However, few health state...
16.
Trinkley K, Wright G, Allen L, Bennett T, Glasgow R, Hale G, et al.
Appl Clin Inform
. 2023 Oct;
14(5):822-832.
PMID: 37852249
Objectives: In a randomized controlled trial, we found that applying implementation science (IS) methods and best practices in clinical decision support (CDS) design to create a locally customized, "enhanced" CDS...
17.
Zhang T, Gephart S, Subbian V, Boyce R, Villa-Zapata L, Tan M, et al.
Appl Clin Inform
. 2023 Oct;
14(4):779-788.
PMID: 37793617
Objective: Despite the benefits of the tailored drug-drug interaction (DDI) alerts and the broad dissemination strategy, the uptake of our tailored DDI alert algorithms that are enhanced with patient-specific and...
18.
Gomez-Lumbreras A, Mercadal Vilchez S, Villa-Zapata L, Malone D, Couriel D
Leuk Lymphoma
. 2023 Sep;
64(13):2071-2080.
PMID: 37708442
Chimeric antigen receptor (CAR) T-cell therapy presents a promising treatment for hematologic malignancies, displaying high efficacy but not being exempt from toxicity. In this observational study, we assessed adverse events...
19.
Duong K, Nguyen D, Chaiyakunapruk N, Nelson R, Malone D
Pharmacogenomics
. 2023 Sep;
24(13):713-724.
PMID: 37706247
is strongly associated with allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) in Vietnam. This study assessed the cost-effectiveness of this testing to prevent SJS/TEN. A model was developed to compare three...
20.
Edelman S, Goldman J, Malone D, Preblick R, Munaga K, Li X, et al.
Clin Diabetes
. 2023 Jul;
41(3):425-434.
PMID: 37456096
People with type 2 diabetes receiving a second-generation basal insulin (BI) analog may be switched to a first-generation formulation for financial reasons or changes in health insurance. However, because second-generation...